Oliviero James F III's Form 4 filing
Checkpoint Therapeutics, Inc. (CKPT) · filed Jul 1, 2022
- Accession no.
- 0001104659-22-076976
- Filed
- Jul 1, 2022
- Trade date
- Jun 17-23, 2022
- Filing delay
- 14 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $301.1K. It was filed 14 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Oliviero James F IIICIK 0001434718 | Director, Officer (CEO, President and Director) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 17, 2022 | COMMON STOCK | SSaleDisposed | −228,000 | $1.09F1 | −$248,520 | 2,610,003 | Direct | |
| Jun 21, 2022 | COMMON STOCK | SSaleDisposed | −21,000 | $1.09F3 | −$22,890 | 2,589,003 | Direct | |
| Jun 22, 2022 | COMMON STOCK | SSaleDisposed | −12,000 | $1.09F4 | −$13,080 | 2,577,003 | Direct | |
| Jun 23, 2022 | COMMON STOCK | SSaleDisposed | −15,000 | $1.11F5 | −$16,650 | 2,562,003 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.06 to $1.12. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.06 to $1.12. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.09 to $1.10. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F5
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $1.11 to $1.13. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.